Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.
- DOI
- 10.1002/dmrr.70188
- Published
- 2026 Jul
- Container
- Diabetes/metabolism research and reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/dmrr.70188,
title = {Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.},
author = {Lin JL and Hsu C and Lo SW and Nigam N and Shenoi M and Tu YF and Bhanderi H and Chen CC and Su YJ and Chang HC and Gau SY},
year = {2026},
journal = {Diabetes/metabolism research and reviews},
doi = {10.1002/dmrr.70188},
url = {https://doi.org/10.1002/dmrr.70188}
}RIS
TY - JOUR TI - Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia. AU - Lin JL AU - Hsu C AU - Lo SW AU - Nigam N AU - Shenoi M AU - Tu YF AU - Bhanderi H AU - Chen CC AU - Su YJ AU - Chang HC AU - Gau SY PY - 2026 JO - Diabetes/metabolism research and reviews DO - 10.1002/dmrr.70188 UR - https://doi.org/10.1002/dmrr.70188 ER -
APA
JL, L., C, H., SW, L., N, N., M, S., YF, T., H, B., CC, C., YJ, S., HC, C., & SY, G. (2026). Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.. Diabetes/metabolism research and reviews. https://doi.org/10.1002/dmrr.70188
Source records
- pubmed · retrieved 2026-09-25T04:47:58.287Z